Zimmer Biomet Holdings, Inc. (ZBH) stock analysis

In our weekly check, Zimmer Biomet Holdings, Inc. is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 18 pass, warnings: 5, red flags: 2.

About Zimmer Biomet Holdings, Inc.

Zimmer Biomet Holdings, Inc. is a Healthcare company (Medical Devices) based in the United States, listed on NYSE as ZBH.

What our checks show for ZBH

Red flags

Warning signs

Strengths

Next earnings report: 2027-02-09

Similar companies

GKOS · SNN · PEN · DXCM · ALGN · PODD

Questions

What grade does Zimmer Biomet Holdings, Inc. (ZBH) have?

In our weekly check, Zimmer Biomet Holdings, Inc. is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 18 pass, warnings: 5, red flags: 2. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of ZBH stock?

This week's biggest flags for Zimmer Biomet Holdings, Inc.: Deep past fall, Slow recovery after falls, High debt. In total 7 of 25 checks show a warning or a red flag.

What does Zimmer Biomet Holdings, Inc. do?

Zimmer Biomet Holdings, Inc. is a Healthcare company (Medical Devices) based in the United States, listed on NYSE as ZBH.

When does Zimmer Biomet Holdings, Inc. report earnings next?

The next earnings report is expected on 2027-02-09. We re-run the checks every week, so the grade can change after it.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis